•Particle beam therapy yields excellent short-term treatment outcomes among NPC patients.•Particle beam therapy is generally safe in primary and recurrent NPC patients, with ≥G3 late toxicity rates of 20 % or less.•An approximately 5% mortality rate was reported among recurrent NPC patients.Particle beam therapy is generally safe in primary and recurrent NPC patients, with ≥G3 late toxicity rates of 20 % or less.
